Luke Ogonda

TL;DR: Minimally invasive total hip arthroplasty performed through a single-incision posterior approach by a high-volume hip surgeon with extensive experience in less invasive approaches to the hip is safe and reproducible, however, it offers no significant benefit in the early postoperative period compared with a standard incision.

TL;DR: A randomised, controlled trial involving 150 patients with a pre-operative level of haemoglobin of 13.0 g/dl or less to compare the effect of either topical fibrin spray or intravenous tranexamic acid on blood loss after total knee replacement.

TL;DR: There was no improvement in early post-operative gait for those patients who received THR using the minimally invasive technique and there was no significant improvement in the gait kinematics of the MI group compared to the SI group either 2 days post-operatively or 6 weeks post- operatively.

TL;DR: The shorter incision offered no significant improvement in patient ability in relation to transfer from lying to sitting, transfer from sitting to standing, mobilizing or weight-bearing, and there was no difference between groups with respect to walking aids at six-week review.

TL;DR: With individualised risk assessment and as part of a multimodal approach, Aspirin is safe to use as the main thromboprophylactic agent in primary arthroplasty and it is not associated with an increased incidence of symptomatic DVT, PE or death.